Related Experiment Video
Updated: Mar 18, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
CHYLOTHORAX IN PARACOCCIDIOIDOMYCOSIS
Flávia Fonseca Fernandes1, Victor Oliveira Alves1, Tarquino Erastides Gavilanes Sánchez2
1Escola Superior de Ciências da Saúde, Hospital Regional da Asa Norte, Medical School, Internal Medicine Unit. Brasília, DF, Brazil.
This case report details a fatal instance of paracoccidioidomycosis presenting with unusual chylothorax and breast mass. It highlights the critical need to consider this fungal infection in differential diagnoses for such conditions.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Medicine
Background:
- Paracoccidioidomycosis is a systemic fungal infection endemic to Latin America.
- It typically affects the lungs and reticuloendothelial system but can manifest with diverse clinical presentations.
Observation:
- A 52-year-old woman presented with prolonged fever, significant weight loss, generalized lymphadenopathy, skin lesions, and a breast mass.
- Imaging revealed widespread lymphadenopathy, splenomegaly, pleural effusion, and ascites consistent with chylous effusions.
- Histopathology of biopsies confirmed Paracoccidioides brasiliensis, identifying large yeast cells with characteristic budding.
Findings:
- The patient was diagnosed with paracoccidioidomycosis, complicated by chylothorax and chylous ascites.
- Despite treatment with liposomal amphotericin B and dietary modifications, her condition rapidly deteriorated.
- She developed pneumonia, septic shock, and respiratory failure, ultimately succumbing to the illness.
Implications:
- This case underscores the importance of including paracoccidioidomycosis in the differential diagnosis of chylothorax and breast masses, particularly in endemic regions.
- It highlights the potential for rare and severe presentations of this mycosis.
- Further research into the mechanisms of chylous effusion development in paracoccidioidomycosis is warranted.
Related Concept Videos
Pneumothorax-II
Clinical Manifestations:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

